888-899-6266        info@BioCoreUSA.com   
0 item(s) $0.00 
 
TISSUE ARRAYS
 
B-63End-1Endometrioid cancer tissue array, including pathology grade, TNM and clinical stage, 63 cases/63 cores
Zoom
Cores63Cases63
Row number7Column number9
Core Diameter(mm)1.5Thickness(µm)5.0
Tissue Array TypeFFPESpeciesHuman
QA/QCH&E and IHC confirmed
ApplicationsRoutine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.
Notes1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better.

2.Bake the slides for 60 minutes at 65℃ before the experiment.

3.Please choose a gentle repair method to avoid tissue detachment.

Product name:B-63End-1
 
Endometrioid cancer tissue array, including pathology grade, TNM and clinical stage, 63 cases/63 cores
 
Price: $255.00
 
PLEASE SELECT TYPE
 
Qty:
 
To Check Overlapping Cases
 
 
Legend:
Ute
-Uterus
 
Malignant (IA)
 
Malignant (IB)
 
Malignant (II)
 
Malignant (IIB)
 
Malignant (IIIA)
 
Malignant (IIIC)
 
NAT (*)
 
Normal (*)
TISSUE  ARRAYS B-63End-1
1
2
3
4
5
6
7
8
9
A
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
B
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
C
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
D
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
E
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
F
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
G
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
 
PosNoAgeSexOrgan_Anatomic_SitePathology_diagnosisGradeTNMStageTypeTumor Size
A1135FUterusEndometrioid adenocarcinoma (sparse)1T2N0M0IIMalignant*
A2257FUterusEndometrioid adenocarcinoma1T1aN0M0IAMalignant*
A3357FUterusEndometrioid adenocarcinoma (sparse)1T1bN0M0IBMalignant*
A4438FUterusEndometrioid adenocarcinoma1T1bN0M0IBMalignant*
A5549FUterusEndometrioid adenocarcinoma1T1aN0M0IAMalignant5*5
A6647FUterusEndometrioid adenocarcinoma1T1bN0M0IBMalignant9*9
A7756FUterusEndometrioid adenocarcinoma1T1aN0M0IAMalignant3*2.5*1.2
A8853FUterusEndometrioid adenocarcinoma1T1aN0M0IAMalignant6*4*4
A9954FUterusEndometrioid adenocarcinoma1T1aN0M0IAMalignant2.5*2*0.5
B11050FUterusEndometrioid adenocarcinoma1T1bN0M0IBMalignant11*10*4
B21137FUterusEndometrioid adenocarcinoma1T1bN0M0IBMalignant6*4.5*3
B31253FUterusEndometrioid adenocarcinoma (sparse)1T1aN0M0IAMalignant9*8*8
B41368FUterusEndometrioid adenocarcinoma1T1bN0M0IBMalignant7*4*4
B51454FUterusEndometrioid adenocarcinoma1T1bN0M0IBMalignant2*1.5*1
B61543FUterusEndometrioid adenocarcinoma1T1bN0M0IBMalignant8*7*6
B71649FUterusEndometrioid adenocarcinoma1T1aN0M0IAMalignant2.5*1
B81750FUterusEndometrioid adenocarcinoma1T1aN0M0IAMalignant4*2
B91843FUterusEndometrioid adenocarcinoma1T1aN0M0IAMalignant2*2
C11953FUterusEndometrioid adenocarcinoma1T2N0M0IIMalignant9*9*4
C22037FUterusEndometrioid adenocarcinoma1T1bN0M0IBMalignant4*3*1.5
C32133FUterusEndometrioid adenocarcinoma1--2T1bN0M0IBMalignant11*9*4
C42256FUterusEndometrioid adenocarcinoma2T1bN0M0IBMalignant5*3.5
C52370FUterusEndometrioid adenocarcinoma2T1bN1M0IIICMalignant6*4*4
C62452FUterusEndometrioid adenocarcinoma2T1bN0M0IBMalignant4*3*2
C72546FUterusEndometrioid adenocarcinoma2T1bN0M0IBMalignant3.5*2*0.8
C82661FUterusEndometrioid adenocarcinoma2T2N0M0IIMalignant3*2
C92770FUterusEndometrioid adenocarcinoma2T1aN0M0IAMalignant9*3.5*2.5
D12830FUterusEndometrioid adenocarcinoma2T1bN0M0IBMalignant*
D22957FUterusEndometrioid adenocarcinoma2T1bN0M0IBMalignant*
D33052FUterusEndometrioid adenocarcinoma2T1aN0M0IAMalignant*
D43158FUterusEndometrioid adenocarcinoma (sparse)2T1aN0M0IAMalignant*
D53246FUterusEndometrioid adenocarcinoma2T1aN0M0IAMalignant*
D63374FUterusEndometrioid adenocarcinoma2T1bN0M0IBMalignant3*3*2
D73459FUterusEndometrioid adenocarcinoma2T1bN0M0IBMalignant8*3*2.5
D83554FUterusEndometrioid adenocarcinoma2T2N0M0IIMalignant2.5*2*1
D93650FUterusEndometrioid adenocarcinoma2T1bN0M0IBMalignant3*2
E13770FUterusEndometrioid adenocarcinoma2T2N0M0IIMalignant1.5*4.5*2
E23852FUterusEndometrioid adenocarcinoma2T1bN0M0IBMalignant4*3*2
E33968FUterusEndometrioid adenocarcinoma2T3aN0M0IIIAMalignant8*6*4
E44054FUterusEndometrioid adenocarcinoma with necrosis2T1aN0M0IAMalignant9*5*3
E54150FUterusEndometrioid adenocarcinoma2T3aN0M0IIIAMalignant6*4*2.5
E64258FUterusEndometrioid adenocarcinoma2T1bN0M0IBMalignant5*3*3
E74343FUterusEndometrioid adenocarcinoma2T1bN0M0IBMalignant7*3*3
E84479FUterusEndometrioid adenocarcinoma2T1aN0M0IAMalignant4*3*0.8
E94560FUterusEndometrioid adenocarcinoma2T1bN0M0IBMalignant5*5*3
F14663FUterusEndometrioid adenocarcinoma with necrosis2--3T3aN0M0IIIAMalignant9*3*2.5
F24758FUterusEndometrioid adenocarcinoma with necrosis2--3T1bN0M0IBMalignant10*9*7
F34849FUterusEndometrioid adenocarcinoma3T2N0M0IIMalignant5*5*4
F44953FUterusEndometrioid adenocarcinoma3T3aN0M0IIIAMalignant7*6*4
F55060FUterusEndometrioid adenocarcinoma3T1aN0M0IAMalignant4*3*2.5
F65151FUterusEndometrioid adenocarcinoma3T1bN0M0IBMalignant8*4.5*4.5
F75251FUterusEndometrioid adenocarcinoma3T3aN0M0IIIAMalignant4*3
F85353FUterusEndometrioid adenocarcinoma3T1bN0M0IBMalignant4*2.5*1.5
F95462FUterusEndometrioid adenocarcinoma3T1bN0M0IBMalignant3.5*3*1.2
G15543FUterusEndometrioid adenocarcinoma with necrosis3T1bN0M0IBMalignant3.5*3*2.5
G25666FUterusEndometrioid adenocarcinoma3T3aN0M0IIIAMalignant*
G35763FUterusEndometrioid adenocarcinoma3T1bN0M0IBMalignant*
G45855FUterusEndometrioid adenocarcinoma3T1bN0M0IBMalignant*
G55952FUterusEndometrioid adenocarcinoma3T2bN0M0IIBMalignant*
G66062FUterusEndometrioid adenocarcinoma3T1bN0M0IBMalignant3*2*1
G76152FUterusEndometrial tissue***NAT*
G86246FUterusEndometrial tissue***NAT*
G96354FUterusEndometrial tissue***Normal*
Tissue Marker
 
 
BioCoreUSA Corporation
6024 Ridge Ave, Suite 116-236
Philadelphia PA 19128
United States
 
CONTACT US
Email:
Customerservices@biocoreusa.com
Info@biocoreusa.com
TEL: 888-899 6266
SUPPORT
Delivery
Privacy Policy
Terms & Conditions
FAQs